HESI THRIVE 2024 Cycle Begins Soon: Open Call For LOI’s
Monday November 13, 2023 - Monday April 8th 2024
The biomedical field has made tremendous strides in turning many cancers into survivable diseases. However, treatment-related effects can:
- Impact a patient’s ability to adhere to and realize the full benefit of existing therapies;
- Make daily tasks challenging and reduce overall quality of life;
- Lead to significantly higher incidence of severe chronic illness in survivors;
- Include cardiac dysfunction or failure, pulmonary problems, neurological issues, liver toxicity, and endocrine disorders among others.
THRIVE fills a critical gap in funding for foundational research in support of future protective therapies, mitigation strategies and a next generation of therapy and therapy-support that will enhance the ability for cancer patients and survivors to THRIVE.
JOIN US IN MAKING A DIFFERENCE!